Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera

Molecular and Biochemical Parasitology

Volumn 159, Issue 2, 2008, Pages 121-129

  Bhaumik, Siddhartha Kumar ^a   Singh, Manoj Kumar ^a   Karmakar, Subir ^a   De, Tripti ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Glycophosphoshingo lipid antigen; Immune modulation; Infected macrophage; Leishmania donovani; Patient sera

Indexed keywords

ANTIGEN GLYCOPHOSPHOSPHINGOLIPID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MEMBRANE ANTIGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; IMMUNOSTIMULATION; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECRETION; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CYTOKINES; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MICE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SPHINGOLIPIDS;

LEISHMANIA DONOVANI;

EID: 43049148387     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2008.03.001     Document Type: Article

References (75)

1. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
2. Reiner N.E., Ng W., and McMaster W.R. Parasite-accessory cell-interactions in murine leishmaniasis. 2. Leishmania donovani suppresses macrophage expression of class-I and class-II major histocompatibility complex gene-products. J Immunol 138 (1987) 1926-1932
3. Antoine J.C., Prina E., Courret N., and Lang T. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv Parasitol 58 (2004) 1-68
4. Liew F.Y., Millott S., Parkinson C., Palmer R.M., and Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J Immunol 144 (1990) 4794-4797
5. Gregory D.J., and Olivier M. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 130 Suppl. (2005) S27-S35
6. Olivier M., Gregory D.J., and Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18 (2005) 293-305
7. Murray H.W. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J Immunol 129 (1982) 351-357
8. Buchmuller-Rouiller Y., and Mauel J. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect Immun 55 (1987) 587-593
9. Olivier M., Baimbridge K.G., and Reiner N.E. Stimulus-response coupling in monocytes infected with Leishmania-attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J Immunol 148 (1992) 1188-1196
10. Aguilar-Torrentera F., and Carlier Y. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection. Rev Latinoam Microbiol 43 (2001) 135-142
11. Stanley A.C., and Engwerda C.R. Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85 (2007) 138-147
12. Carvalho E.M., Badaro R., Reed S.G., Jones T.C., and Johnson W.D. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76 (1985) 2066-2069
13. Liew F.Y. Regulation of cell-mediated immunity in leishmaniasis. Curr Top Microbiol Immunol 155 (1990) 53-64
14. De-Majumdar T. Leishmania donovani: purification and partial characterization of a glycophosphosphingolipid antigen expressed on promastigote surface. Exp Parasitol 74 (1992) 251-260
15. De T., and Roy S. Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J Parasitol 85 (1999) 54-59
16. Leeden R.W., and Yu R.K. Ganglioside: structure, isolation and analysis. In: Ginsburg V. (Ed). Methods in Enzymology 83 (1982), Academic Press, New York, NY 139-191
17. Ryu E.K., and MacCross M. Modification of the Dittmer-Lester reagent for the detection of phosphorlipid derivatives on thin layer chromatograms. J Lipid Res 20 (1979) 561-563
18. Kotani M., Tajima Y., Shimoda Y., Ire A., Kubo H., and Tai T. Ganglioside GT1b in rat brain binds to p58, a brain-specific sodium-dependent inorganic phosphate contransporter: expression cloning with a specific monoclonal antibody to ganglioside GT1b-binding protein. J Biochem (Tokyo) 127 (2000) 13-22
19. Ottnad E., Parthasarathy S., Sambrano G.R., et al. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 92 (1995) 1391-1395
20. Aronson N.N., and Touster O. Isolation of rat liver plasma membrane fragments in isotonic sucrose. Methods Enzymol 31 (1974) 90-102
21. Weening R.S., Roos D., and Loos J.A. Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med 83 (1974) 570-577
22. Basu R., Bhaumik S., Basu J.M., Naskar K., De T., and Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol 174 (2005) 7160-7171
23. Jaffe C.L., Bennett E., Grimaldi Jr. G., and McMahon Pratt D. Production and characterization of species specific monoclonal antibodies against Leishmania donovani for immunodiagnosis. J Immunol 133 (1984) 440-447
24. Babior B.M. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med 298 (1998) 659-668
25. Hallett M.B., and Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today 16 (1995) 264-268
26. de Ibarra A., Howard J.G., and Snary D. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location. Parasitology 85 (1982) 523-531
27. Farah F.S., Sarura S.A., and Nuvaysi-Sothi N. The role of the macrophage in cutaneous leishmaniasis. Immunology 29 (1975) 755-758
28. Berman J.D., and Dwyer D.M. Expression of Leishmania antigen on the surface membrane of infected human macrophages in vitro. Clin Exp lmmunol 44 (1981) 342-348
29. Williams K.M., Sacci J.B., and Anthony R.L. Identification and recovery of Leishmania antigen displayed on the surface of mouse peritoneal macrophages infected in vitro. J Immunol 136 (1986) 1853-1858
30. Handman E., Cered R., and Mitchell G.F. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of normal and infected macrophages. Aust J Exp Biol Med 57 (1979) 9-29
31. Basu N., Kole L., Ghosh A., and Das P.K. Expression and characterization of a parasite-specific antigen on macrophages after infection with Leishmania donovani. Mol Cell Biochem 132 (1994) 1-6
32. Handman E., and Goding J.W. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J 4 (1985) 329-336
33. Tolson D.L., Turco S.J., and Pearson T.W. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect Immun 58 (1990) 3500-3507
34. Prigozy T.I., Naidenko O., Qasba P., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667
35. Joyce S., Woods A.S., Yewdel J.W., et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279 (1998) 1541-1544
36. van den Elzen P., Garg S., León L., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437 (2005) 906-910
37. Chiu Y.H., Jayawardena J., Weiss A., et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189 (1999) 103-110
38. Chiu Y.H., Park S.H., Benlagha K., et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nature Immunol 3 (2002) 55-60
39. Roberts T.J., Sriram V., Spence P.M., et al. Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J Immunol 168 (2002) 5409-5414
40. Barral D.C., and Brenner M.B. CD1 antigen presentation: how it works. Nat Rev Immunol 7 (2007) 929-941
41. Neogy A.B., Nandy A., Ghosh Dastidar B., and Chowdhury A.B. Antibody kinetics in kala-azar in response to treatment. Ann Trop Med Parasitol 81 (1987) 727-729
42. Pearson R.D., and Sousa A.Q. Clinical spectrum of leishmaniasis. Clin Infect Dis 22 (1996) 1-13
43. Badaró R., and Duarte M.I.S.L. Leishmaniose visceral (calazar). In: Veronesi R., and Focaccia R. (Eds). Tratado de Infectologia (1997), Atheneu, São Paulo 1234-1259
44. Badaró R., and Reed S.G. Leishmanioses. In: Ávila S.L., and Ferreira A.W. (Eds). Diagnóstico Laboratorial das Principais Doenças Infecciosas e Auto-Imunes (2001), Guanabara Koogan, Rio de Janeiro 255-262
45. Hommel M., Peters W., Ranque J., Quilici M., and Lanotte G. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol 72 (1978) 213-218
46. Bums J.M., Shreffler W.G., Benson D.R., Ghalib H.W., Badaro R., and Reed S.G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci USA 90 (1993) 775-779
47. Reed S.G., Shreffler W.G., Bums J.M., et al. An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg 43 (1990) 632-639
48. Ghose A.C., Haldar J.P., Pal S.C., Mishra B.P., and Mishra K.K. Serological investigations on Indian kala-azar. Clin Exp Immunol 40 (1980) 318-326
49. Galvao-Castro B., Sa Ferreira J.A., Marzochi K.F., Marzochi M.C., Coutinho S.G., and Lambert P.H. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin Exp Immunol 56 (1984) 58-66
50. Minoprio P., Burlen O., Pereira P., et al. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scand J Immunol 28 (1988) 553-561
51. Cordeiro-da-Silva A., Espinoza A.G., Taibi A., Ouaissi A., and Minoprio P. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator. Immunology 94 (1998) 189-196
52. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 12 (1991) 154-159
53. Ryan J.R., Smithyman A.M., Rajasekariah G.-H., Hochberg L., Stiteler J.M., and Martin S.K. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J Clin Microbiol 40 (2002) 1037-1043
54. Ghosh A.K., Dasgupta S., and Ghose A.C. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis. Clin Diag Lab Immunol 2 (1995) 291-296
55. Anam K., Afrin F., Banerjee D., et al. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy. Infect Immun 67 (1999) 6663-6669
56. Kemp K. Cytokine-producing T cell subsets in human leishmaniasis. Arch Immunol Ther Exp (Warsz) 48 (2000) 173-176
57. Maasho K., Satti I., Nylen S., Guzman G., Koning F., and Akuffo H. A leishmania homologue of receptors for activated c-kinase (LACK) induces both interferon-γ and interleukin-10 in natural killer cells of healthy blood donors. J Infect Dis 182 (2000) 570-578
58. Yount W.J., Dorner M.M., Kunkel H.G., and Kabat E.A. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med 127 (1968) 633-646
59. Siber G.R., Schur P.H., Aisenberg A.C., Weitzman S.A., and Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303 (1980) 178-182
60. Dillon D.C., Day C.H., Whittle J.A., Magill A.J., and Reed S.G. Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients. Proc Natl Acad Sci USA 92 (1995) 7981-7985
61. Briere B.F., Servet-Delprat C., Bridon J.M., Saint-Remy J.M., and Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 179 (1994) 757-762
62. Kawano Y., Noma T., and Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 153 (1994) 4948-4958
63. Liew F.Y., and O'Donnell C.A. Immunology of leishmaniasis. Adv Parasitol 32 (1993) 161-259
64. Evans T.G., Thai L., Granger D.L., and Hibbs J.B. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol 151 (1993) 907-915
65. Assreuy J., Cunha F.Q., Epperlein M., et al. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 24 (1994) 672-676
66. Green S.J., Meltzer M.S., Hibbs J.B., and Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by a l-arginine dependent killing mechanism. J Immunol 144 (1990) 278-283
67. Murray H.W., and Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189 (1999) 741-746
68. Murray H.W., Tsai C.W., Liu J., and Ma X. Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect Immun 74 (2006) 4370-4374
69. Reiner N.E. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 15 (1994) 374-381
70. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147 (1991) 3149-3155
71. Vouldoukis I., Riveros-Moreno V., Dugas B., et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA 92 (1995) 7804-7808
72. Kumar P., Pai K., Pandey H.P., and Sundar S. NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. J Med Microbiol 51 (2002) 832-836
73. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 174 (1991) 1549-1555
74. Barral-Netto M., Badaro R., Barral A., et al. Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 163 (1991) 853-857
75. Wilson M.E., Young B.M., Davidson B.L., Mente K.A., and McGowan S.E. The importance of TGF-beta in murine visceral leishmaniasis. J Immunol 161 (1998) 6148-6155